Journal Article

CRISPR/Cas9-Mediated Genome Editing as a Therapeutic Approach for Leber Congenital Amaurosis 10

Barry, Elizabeth, Scaria, Abraham, Yu, Dan, Lukason, Michael, Cheng, Seng H., Ruan, Guo-Xiang

2017

Overview

As the most common subtype of Leber congenital amaurosis (LCA), LCA10 is a severe retinal dystrophy caused by mutations in the CEP290 gene. The most frequent mutation found in patients with LCA10 is a deep intronic mutation in CEP290 that generates a cryptic splice donor site. The large size of the CEP290 gene prevents its use in adeno-associated virus (AAV)-mediated gene augmentation therapy. Here, we show that targeted genomic deletion using the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system represents a promising therapeutic approach for the treatment of patients with LCA10 bearing the CEP290 splice mutation. We generated a cellular model of LCA10 by introducing the CEP290 splice mutation into 293FT cells and we showed that guide RNA pairs coupled with SpCas9 were highly efficient at removing the intronic splice mutation and restoring the expression of wild-type CEP290. In addition, we demonstrated that a dual AAV system could effectively delete an intronic fragment of the Cep290 gene in the mouse retina. To minimize the immune response to prolonged expression of SpCas9, we developed a self-limiting CRISPR/Cas9 system that minimizes the duration of SpCas9 expression. These results support further studies to determine the therapeutic potential of CRISPR/Cas9-based strategies for the treatment of patients with LCA10. LCA10 is caused by mutations in CEP290, which is too large for the gene therapy vector AAV. Here, Ruan et al. show that gene editing using CRISPR/Cas9 represents a promising therapeutic approach to treat LCA10. They also develop a self-limiting CRISPR/Cas9 system to limit duration of Cas9 expression.

• Publisher: Elsevier Inc,Elsevier Limited,American Society of Gene & Cell Therapy
• Subject: Alternative Splicing / Animals / Antigens, Neoplasm - genetics / Cell Cycle Proteins / CEP290 / Clonal deletion / Cloning / CRISPR / CRISPR-Cas Systems / CRISPR/Cas9 / Cytoskeletal Proteins / Deoxyribonucleic acid / DNA / Female / Gene deletion / Gene Editing / Gene Expression / Gene Order / Gene Targeting / Genetic Loci / Genome editing / Genomes / Immune response / Introns / Laboratory animals / LCA10 / Leber congenital amaurosis / Leber Congenital Amaurosis - genetics / Leber Congenital Amaurosis - therapy / Mice / Mutation / Neoplasm Proteins - genetics / Original / Patients / Photoreceptors / Plasmids / Proteins / Retina / Retina - metabolism / Retinal degeneration / Ribonucleic acid / RNA / RNA, Guide, CRISPR-Cas Systems / RNA, Messenger - genetics / Sequence Deletion / Targeted Gene Repair